{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:50:45Z","timestamp":1774529445088,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.eimc.2015.01.010","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T14:31:05Z","timestamp":1424874665000},"page":"579-584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Streptococcus pneumoniae: distribuci\u00f3n de serotipos, sensibilidad antibi\u00f3tica, factores de riesgo y mortalidad en Galicia en un periodo de 2 a\u00f1os"],"prefix":"10.1016","volume":"33","author":[{"given":"Susana","family":"M\u00e9ndez-Lage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Losada-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Agulla-Budi\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.01.010_bib0155","series-title":"Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases","article-title":"Streptococcus pneumonia","author":"Musher","year":"2010"},{"key":"10.1016\/j.eimc.2015.01.010_bib0160","year":"2010","journal-title":"Streptococcus pneumoniae"},{"key":"10.1016\/j.eimc.2015.01.010_bib0165","first-page":"232","article-title":"Consenso sobre la vacunaci\u00f3n anti-neumoc\u00f3cica en el adulto con patolog\u00eda de base","volume":"26","author":"Picazo","year":"2013","journal-title":"Rev Esp Quimioter."},{"key":"10.1016\/j.eimc.2015.01.010_bib0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.medcli.2013.07.023","article-title":"Influencia de la edad en la enfermedad neumoc\u00f3cica invasiva y en la resistencia a antimicrobianos","volume":"143","author":"P\u00e9rez-Rodr\u00edguez","year":"2014","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.eimc.2015.01.010_bib0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0180","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(00)04222-7","article-title":"Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children","volume":"357","author":"Hausdorff","year":"2001","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2015.01.010_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/649872","article-title":"Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades","volume":"50","author":"Harboe","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0190","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/cid\/cit640","article-title":"Effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: Implications for vaccine strategies","volume":"57","author":"Luj\u00e1n","year":"2013","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0195","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1016\/j.vaccine.2011.05.099","article-title":"Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality","volume":"29","author":"Rodr\u00edguez","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.01.010_bib0200","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"Van Hoek","year":"2012","journal-title":"J Infect."},{"key":"10.1016\/j.eimc.2015.01.010_bib0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40272-013-0047-z","article-title":"13-valent pneumococcal conjugate vaccine: A review of its use in infants, children, and adolescents","volume":"15","author":"Plosker","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.eimc.2015.01.010_bib0210","unstructured":"Direcci\u00f3n de Innovaci\u00f3n e Xesti\u00f3n da Sa\u00fade Publica, Direcci\u00f3n de Asistencia Sanitaria. Vacunaci\u00f3n frente al neumococo. Estudio piloto. Instrucci\u00f3n [monograf\u00eda de internet]. Santiago de Compostela: Direcci\u00f3n de Innovaci\u00f3n e Xesti\u00f3n da Sa\u00fade Publica, Direcci\u00f3n de Asistencia Sanitaria. Conseller\u00eda de Sanidade; 2010 [consultado 14 Nov 2013]. Disponible en: http:\/\/www.sergas.es\/cas\/DocumentacionTecnica\/docs\/SaudePublica\/vacunas\/instruccion%20neumococo_castellano.pdf"},{"key":"10.1016\/j.eimc.2015.01.010_bib0215","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twenty-Fourth Informational Supplement. CLSI document M100-S24. 2014."},{"key":"10.1016\/j.eimc.2015.01.010_bib0220","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/JCM.42.6.2518-2522.2004","article-title":"Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex)","volume":"42","author":"Slotveb","year":"2004","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2015.01.010_bib0225","first-page":"699","article-title":"The quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med."},{"key":"10.1016\/j.eimc.2015.01.010_bib0230","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/infdis\/174.6.1271","article-title":"Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine","volume":"174","author":"Dagan","year":"1996","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0235","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2015.01.010_bib0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","article-title":"Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007","volume":"48","author":"Ardanuy","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0245","doi-asserted-by":"crossref","first-page":"e43619","DOI":"10.1371\/journal.pone.0043619","article-title":"Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): Implications for future vaccination strategies","volume":"7","author":"Ardanuy","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.eimc.2015.01.010_bib0250","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after Introduction of Conjugate Vaccines, United States, 1999-2011","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0255","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1139\/cjm-2013-0614","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012","volume":"59","author":"Demczuk","year":"2013","journal-title":"Can J Microbiol."},{"key":"10.1016\/j.eimc.2015.01.010_bib0260","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1016\/j.vaccine.2011.06.056","article-title":"The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A","volume":"29","author":"Cooper","year":"2011","journal-title":"Vaccine."},{"key":"10.1016\/j.eimc.2015.01.010_bib0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period","volume":"16","author":"Li\u00f1ares","year":"2010","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.eimc.2015.01.010_bib0270","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jinf.2009.12.008","article-title":"Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006","volume":"60","author":"Trotter","year":"2010","journal-title":"J Infect."},{"key":"10.1016\/j.eimc.2015.01.010_bib0275","unstructured":"Cercenado E, Cant\u00f3n R, editores. Detecci\u00f3n fenot\u00edpica de mecanismos de resistencia en grampositivos. [monograf\u00eda de internet]. 2011. Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica; 2011 [consultado 14 Nov 2013]. Disponible en: http:\/\/www.seimc.org\/contenidos\/documentoscientificos\/procedimientosmicrobiologia\/seimc-procedimientomicrobiologia39.pdf"},{"key":"10.1016\/j.eimc.2015.01.010_bib0280","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1128\/JCM.02207-10","article-title":"Increase in prevalence of Streptococcus pneumoniae serotype 6C at eight Children's Hospitals in the United States from 1993 to 2009","volume":"49","author":"Green","year":"2011","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2015.01.010_bib0285","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/jac\/dkr193","article-title":"Trends of invasive serotype 6C pneumococci in Spain: Emergence of a new lineage","volume":"66","author":"Rolo","year":"2011","journal-title":"J Antimicrob Chemother."},{"key":"10.1016\/j.eimc.2015.01.010_bib0290","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s10096-013-1859-z","article-title":"Epidemiology of invasive pneumococcal disease and vaccine provision in a tertiary referral center","volume":"32","author":"Rock","year":"2013","journal-title":"Europ J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0295","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: A meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2015.01.010_bib0300","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1183\/09031936.00041210","article-title":"The paradox in pneumococcal serotypes: Highly invasive does not mean highly lethal","volume":"36","author":"Pletz","year":"2010","journal-title":"Eur Respir J."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T21:54:56Z","timestamp":1537826096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0213005X15000531"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.01.010","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Streptococcus pneumoniae: distribuci\u00f3n de serotipos, sensibilidad antibi\u00f3tica, factores de riesgo y mortalidad en Galicia en un periodo de 2 a\u00f1os","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}